Intraop Medical

Executive Summary

Intraop Medical is a medical device company advancing intraoperative radiation therapy (IORT) and FLASH radiotherapy. Its flagship product, the Mobetron, a mobile electron beam linear accelerator, is already commercialized for IORT and non-invasive skin cancer treatment, establishing a clinical foothold. The company is leveraging this platform to pioneer ultra-high dose rate (FLASH) radiotherapy, which has shown promise in preclinical studies for reducing normal tissue toxicity while maintaining tumor control. With over 20 years of history and an installed base, Intraop is uniquely positioned to translate FLASH research into clinical practice, potentially revolutionizing radiotherapy. The company is privately held and operates at a pre-clinical stage for its FLASH program, though the Mobetron platform is FDA-cleared and used clinically.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for FLASH-enabled Mobetron upgrade60% success
• Q2 2026Publication of first-in-human FLASH radiotherapy results using Mobetron50% success
• Q2 2026Strategic partnership with a major cancer center for FLASH clinical trials70% success